Clinical models and biochemical predictors of VTE in lung cancer.

about

Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.

P2860

Q38307997-334B8B28-BAA5-4006-866F-D523EF9065FF Q39123264-BDDCD05D-F9B7-470A-90D3-87575164ECB5

P2860

Clinical models and biochemical predictors of VTE in lung cancer.

Item

http://www.wikidata.org/entity/Q38205701

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical models and biochemical predictors of VTE in lung cancer.

@en

type

Item

label

Clinical models and biochemical predictors of VTE in lung cancer.

@en

prefLabel

Clinical models and biochemical predictors of VTE in lung cancer.

@en

P1476

Clinical models and biochemical predictors of VTE in lung cancer.

@en

P2093

F Guadagni

http://www.w3.org/2001/XMLSchema#string

F La Farina

http://www.w3.org/2001/XMLSchema#string

M Roselli

http://www.w3.org/2001/XMLSchema#string

S Mariotti

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation

Role of tissue factor in hemostasis, thrombosis, and vascular development

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Microvesicle-associated tissue factor and Trousseau's syndrome

P2888

s10555-014-9500-x

P304

771-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-014-9500-X

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrizia Ferroni

Silvia Riondino

Mario Roselli

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045642263

http://www.w3.org/2001/XMLSchema#string

P698

24748012

http://www.w3.org/2001/XMLSchema#string

Clinical models and biochemical predictors of VTE in lung cancer.

about

P2860

P2860

Clinical models and biochemical predictors of VTE in lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698